$MVST
Microvast Holdings, Inc. Stock $mvst

$mvst Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000176068923000026 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$80.12M	$74.95M
YoY Change	107.47%	16.36%
Cost Of Revenue	$62.23M	$63.49M
YoY Change	69.93%	6.58%
Gross Profit	$17.88M	$11.46M
YoY Change	797.34%	136.75%
Gross Profit Margin	22.32%	15.29%
Selling, General & Admin	$31.43M	$29.46M
YoY Change	11.68%	-26.62%
% of Gross Profit	175.76%	257.02%
Research & Development	$13.24M	$9.507M
YoY Change	15.57%	-7.19%
% of Gross Profit	74.04%	82.95%
Depreciation & Amortization	$5.036M	$5.099M
YoY Change	2.34%	-2.07%
% of Gross Profit	28.16%	44.49%
Operating Expenses	$44.67M	$38.96M
YoY Change	12.8%	-22.67%
Operating Profit	-$26.35M	-$26.87M
YoY Change	-28.96%	-40.26%
Interest Expense	$491.0K	$487.0K
YoY Change	-36.56%	-45.59%
% of Operating Profit
Other Income/Expense, Net	$127.0K	-$243.0K
YoY Change	-63.61%	-2530.0%
Pretax Income	-$26.17M	-$26.08M
YoY Change	-28.38%	-40.98%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$26.13M	-$26.09M
YoY Change	-28.5%	-40.95%
Net Earnings / Revenue	-32.62%	-34.81%
Basic Earnings Per Share	-$0.08	-$0.08
Diluted Earnings Per Share	-$0.08	-$0.08
COMMON SHARES
Basic Shares Outstanding	316.3M shares	309.4M shares
Diluted Shares Outstanding	313.1M shares	307.7M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$92.89M	$168.3M
YoY Change	-68.6%	-49.6%
Cash & Equivalents	$67.40M	$142.8M
Short-Term Investments	$25.50M	$25.49M
Other Short-Term Assets	$47.64M	$48.16M
YoY Change	-53.4%	-37.93%
Inventory	$126.9M	$86.76M
Prepaid Expenses
Receivables	$116.3M	$106.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$403.9M	$427.0M
YoY Change	-28.83%	-30.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$549.5M	$497.8M
YoY Change	91.92%	78.8%
Goodwill
YoY Change
Intangibles	$3.210M	$3.343M
YoY Change	89.27%	90.16%
Long-Term Investments
YoY Change
Other Assets	$28.54M	$36.60M
YoY Change	-45.96%	-26.49%
Total Long-Term Assets	$612.7M	$570.7M
YoY Change	51.12%	58.4%
TOTAL ASSETS
Total Short-Term Assets	$403.9M	$427.0M
Total Long-Term Assets	$612.7M	$570.7M
Total Assets	$1.017B	$997.7M
YoY Change	4.48%	2.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$95.29M	$54.32M
YoY Change	164.91%	37.25%
Accrued Expenses	$10.22M	$11.03M
YoY Change	-87.15%	-83.48%
Deferred Revenue	$54.48M	$53.06M
YoY Change	726.86%	1064.06%
Short-Term Debt	$24.82M	$18.12M
YoY Change	253.08%	105.71%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$336.4M	$292.7M
YoY Change	45.1%	29.37%
LONG-TERM LIABILITIES
Long-Term Debt	$74.73M	$74.92M
YoY Change	-8.7%	70.7%
Other Long-Term Liabilities	$20.82M	$32.05M
YoY Change	-29.59%	-0.39%
Total Long-Term Liabilities	$20.82M	$32.05M
YoY Change	-29.59%	-0.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$336.4M	$292.7M
Total Long-Term Liabilities	$20.82M	$32.05M
Total Liabilities	$449.2M	$418.0M
YoY Change	25.81%	31.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$873.0M	-$846.8M
YoY Change	15.25%	17.47%
Common Stock	$32.00K	$31.00K
YoY Change	3.23%	3.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$565.3M	$577.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.017B	$997.7M
YoY Change	4.48%	2.68%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$26.13M	-$26.09M
YoY Change	-28.5%	-40.95%
Depreciation, Depletion And Amortization	$5.036M	$5.099M
YoY Change	2.34%	-2.07%
Cash From Operating Activities	-$29.34M	-$29.84M
YoY Change	-693.93%	-22.73%
INVESTING ACTIVITIES
Capital Expenditures	$59.94M	$57.71M
YoY Change	-456.66%	-314.9%
Acquisitions
YoY Change
Other Investing Activities	$224.0K	$132.0K
YoY Change	22300.0%	13100.0%
Cash From Investing Activities	-$59.72M	-$57.58M
YoY Change	255.35%	114.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.863M	909.0K
YoY Change	-81.98%	-123.51%
NET CHANGE
Cash From Operating Activities	-29.34M	-29.84M
Cash From Investing Activities	-59.72M	-57.58M
Cash From Financing Activities	6.863M	909.0K
Net Change In Cash	-82.20M	-86.51M
YoY Change	-413.42%	24.76%
FREE CASH FLOW
Cash From Operating Activities	-$29.34M	-$29.84M
Capital Expenditures	$59.94M	$57.71M
Free Cash Flow	-$89.28M	-$87.55M
YoY Change	-510.56%	644.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	300565515	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	300565515	shares
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1156000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-215000	usd
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307742032	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307742032	shares
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605829000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-26078000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17968000	usd
CY2023Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-18002000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	579717000	usd
	us-gaap	Profit Loss ProfitLoss	-55649000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2174000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36029000	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-15814000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	579717000	usd
	us-gaap	Profit Loss ProfitLoss	-87958000	usd
	us-gaap	Profit Loss ProfitLoss	-55649000	usd
	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	13000	usd
	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	826000	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	10377000	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	9797000	usd
	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	283000	usd
	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	399000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1112000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1465000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	53650000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	35779000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	380000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-832000	usd
	mvst	Provision For Obsolete Inventories ProvisionForObsoleteInventories	1919000	usd
	mvst	Provision For Obsolete Inventories ProvisionForObsoleteInventories	928000	usd
	mvst	Impairment Loss From Property Plant And Equipment ImpairmentLossFromPropertyPlantAndEquipment	493000	usd
	mvst	Impairment Loss From Property Plant And Equipment ImpairmentLossFromPropertyPlantAndEquipment	51000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	6235000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	5450000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	20647000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	19808000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21856000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10251000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15906000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16610000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1689000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6842000	usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	85000	usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	0	usd
	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	19260000	usd
	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	5850000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-111000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-199000	usd
	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	19237000	usd
	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	-15517000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	808000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11771000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3230000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-968000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-13704000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1020000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	15838000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3364000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63535000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41008000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	67915000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93630000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	419000	usd
	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	2000	usd
	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	648000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67913000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93401000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	13466000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	9232000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	17332000	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3939000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3866000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5293000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3863000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3182000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-139177000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-132298000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	536109000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	302617000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	396932000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	170319000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	333867000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	142766000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	63065000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27553000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396932000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170319000	usd
CY2022Q2	mvst	Payable For Purchase Of Property Plant And Equipment PayableForPurchaseOfPropertyPlantAndEquipment	28755000	usd
CY2023Q2	mvst	Payable For Purchase Of Property Plant And Equipment PayableForPurchaseOfPropertyPlantAndEquipment	82968000	usd
	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp.(“Tuscan”) consummated the previously announced merger (the “Merger”), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling electronic power products for electric vehicles and energy storage across the globe.</span></div>
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64414000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74953000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101082000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121926000	usd
CY2022Q2	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	70000	usd
CY2023Q2	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	1068000	usd
	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	549000	usd
	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	2485000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4407000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3468000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	119304000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106094000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21001000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	20949000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2946000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	123711000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	109562000	usd
CY2022Q1	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5354000	usd
CY2023Q1	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3270000	usd
CY2021Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5005000	usd
CY2022Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4407000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	925000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	262000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	380000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-832000	usd
CY2022Q2	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	153000	usd
CY2023Q2	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	0	usd
	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	153000	usd
	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	66000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	121000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	121000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-298000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-185000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-270000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-162000	usd
CY2022Q2	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5828000	usd
CY2023Q2	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3468000	usd
CY2022Q2	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5828000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	48747000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	49333000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	29331000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20347000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6174000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17080000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	84252000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	86760000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	1448000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	928000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1919000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	928000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3493000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5420000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1857000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2077000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1636000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3343000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	61000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	120000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	249000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	244000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	482000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	479000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	477000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	471000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	382000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	808000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3343000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13044000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7855000	usd
CY2022Q4	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	29183000	usd
CY2023Q2	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	82968000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8608000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9091000	usd
CY2022Q4	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	4716000	usd
CY2023Q2	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	4274000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2641000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	3057000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	298000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	755000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	6296000	usd
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	5503000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1934000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2946000	usd
CY2022Q4	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	66720000	usd
CY2023Q2	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	116449000	usd
CY2022Q1	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	51431000	usd
CY2023Q1	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	39610000	usd
CY2021Q4	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	58458000	usd
CY2022Q4	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	42060000	usd
CY2022Q2	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	3550000	usd
CY2023Q2	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	2920000	usd
	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	6235000	usd
	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	5450000	usd
CY2022Q2	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	8590000	usd
CY2023Q2	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	3338000	usd
	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	18600000	usd
	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	8510000	usd
CY2022Q2	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	-2688000	usd
CY2023Q2	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	-2084000	usd
	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	-2390000	usd
	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	-1892000	usd
CY2022Q2	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	43703000	usd
CY2023Q2	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	37108000	usd
CY2022Q2	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	43703000	usd
CY2023Q2	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	37108000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13044000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	7855000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	29016000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	29253000	usd
CY2022Q4	mvst	Product Warranty Total ProductWarrantyTotal	42060000	usd
CY2023Q2	mvst	Product Warranty Total ProductWarrantyTotal	37108000	usd
CY2022Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	504000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1028000	usd
CY2022Q1	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	13335000	usd
CY2023Q1	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	50964000	usd
CY2021Q4	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	13301000	usd
CY2022Q4	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	46395000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	13466000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4848000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	13466000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	9232000	usd
CY2022Q2	mvst	Repayments Of Principal RepaymentsOfPrincipal	17332000	usd
CY2023Q2	mvst	Repayments Of Principal RepaymentsOfPrincipal	3939000	usd
	mvst	Repayments Of Principal RepaymentsOfPrincipal	17332000	usd
	mvst	Repayments Of Principal RepaymentsOfPrincipal	3939000	usd
CY2022Q2	mvst	Exchange Difference ExchangeDifference	-662000	usd
CY2023Q2	mvst	Exchange Difference ExchangeDifference	-2727000	usd
	mvst	Exchange Difference ExchangeDifference	-628000	usd
	mvst	Exchange Difference ExchangeDifference	-2542000	usd
CY2022Q2	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	8807000	usd
CY2023Q2	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	49146000	usd
CY2022Q2	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	8807000	usd
CY2023Q2	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	49146000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	17398000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	18117000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	28997000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	31029000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	46395000	usd
CY2022Q4	mvst	Pledged Buildings PledgedBuildings	27245000	usd
CY2023Q2	mvst	Pledged Buildings PledgedBuildings	25088000	usd
CY2022Q4	mvst	Pledged Land Use Rights PledgedLandUseRights	12639000	usd
CY2023Q2	mvst	Pledged Land Use Rights PledgedLandUseRights	11878000	usd
CY2022Q4	mvst	Pledged Total Asset PledgedTotalAsset	39884000	usd
CY2023Q2	mvst	Pledged Total Asset PledgedTotalAsset	36966000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	29016000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	29253000	usd
CY2022Q4	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	3066000	usd
CY2023Q2	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	2793000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32082000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32046000	usd
CY2022Q4	mvst	Long Term Bonds Payable LongTermBondsPayable	43888000	usd
CY2023Q2	mvst	Long Term Bonds Payable LongTermBondsPayable	43888000	usd
CY2018Q4	mvst	Bond Loan BondLoan	87776000	usd
CY2018Q4	mvst	Bond Loan BondLoan	600000000	cny
CY2018Q4	mvst	Equity Holding Pledged Percentage EquityHoldingPledgedPercentage	0.1239
	mvst	Debt Instrument Convertible Amount Subsidiary Value Threshold DebtInstrumentConvertibleAmountSubsidiaryValueThreshold	950000000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14629000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14630000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12
CY2023Q2	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	43888000	usd
CY2023Q2	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	300000000	cny
CY2021Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	27600000	shares
CY2021Q3	mvst	Class Of Warrant Or Right Exercisable Period ClassOfWarrantOrRightExercisablePeriod	P30D
CY2021Q3	mvst	Warrant Term WarrantTerm	P5Y
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	231420000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	71197000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	302617000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	126000	usd
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	126000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	142766000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	27553000	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	170319000	usd
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	109000	usd
CY2023Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	109000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1105000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	126000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	820000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	17000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	285000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	109000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1069000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1949000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	108000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	179000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y3M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
	us-gaap	Operating Lease Payments OperatingLeasePayments	1958000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5850000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2092000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3280000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2798000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2546000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2416000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1839000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	11666000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	26637000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5688000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	20949000	usd
CY2021Q3	us-gaap	Standby Bond Purchase Commitment Expiration Period StandbyBondPurchaseCommitmentExpirationPeriod	P10Y
CY2021Q3	mvst	Exchange Ratio ExchangeRatio	160.3
CY2021Q3	mvst	Common Stock Reserved For Esop Plan CommonStockReservedForESOPPlan	0.05
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	33503657	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.19
CY2021Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.95
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2400000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	120225	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.92
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	35783432	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.13
CY2022Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.84
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	35783432	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.13
CY2022Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.84
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1122100	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.28
CY2022Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	5.29
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36091071	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.08
CY2022Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	240000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.67
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	347317	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.28
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.86
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	35983754	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.04
CY2023Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	35983754	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.04
CY2023Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12563621	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.14
CY2023Q2	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	4.87
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M18D
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	60805000	usd
	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P1Y1M6D
CY2023Q2	mvst	Aggregate Intrinsic Value Of The Share Options AggregateIntrinsicValueOfTheShareOptions	85000	usd
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	5903000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	7827000	usd
CY2022Q2	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	1882000	usd
CY2023Q2	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	1525000	usd
	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	3816000	usd
	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	3029000	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	24558000	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	12419000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	42694000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	24587000	usd
CY2022Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2649000	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2693000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	7788000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	5707000	usd
CY2022Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1328000	usd
CY2023Q2	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1213000	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	4249000	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	2456000	usd
CY2022Q2	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	102000	usd
CY2023Q2	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	149000	usd
	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	264000	usd
	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	289000	usd
CY2022Q2	mvst	Stock Based Compensation Total StockBasedCompensationTotal	30519000	usd
CY2023Q2	mvst	Stock Based Compensation Total StockBasedCompensationTotal	17999000	usd
	mvst	Stock Based Compensation Total StockBasedCompensationTotal	58811000	usd
	mvst	Stock Based Compensation Total StockBasedCompensationTotal	36068000	usd
CY2022Q2	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-44182000	usd
CY2023Q2	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-26089000	usd
	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-87958000	usd
	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-55670000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	300565515	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	300565515	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307742032	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307742032	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	299709069	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	299709069	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307728460	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307728460	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q2	mvst	Shares Issuable Upon Exercise Of Share Options SharesIssuableUponExerciseOfShareOptions	34145152	shares
CY2023Q2	mvst	Shares Issuable Upon Exercise Of Share Options SharesIssuableUponExerciseOfShareOptions	36123034	shares
	mvst	Shares Issuable Upon Exercise Of Share Options SharesIssuableUponExerciseOfShareOptions	33815815	shares
	mvst	Shares Issuable Upon Exercise Of Share Options SharesIssuableUponExerciseOfShareOptions	36088798	shares
CY2022Q2	mvst	Shares Issuable Upon Vesting Of Non Vested Shares SharesIssuableUponVestingOfNonVestedShares	1347060	shares
CY2023Q2	mvst	Shares Issuable Upon Vesting Of Non Vested Shares SharesIssuableUponVestingOfNonVestedShares	3979361	shares
	mvst	Shares Issuable Upon Vesting Of Non Vested Shares SharesIssuableUponVestingOfNonVestedShares	1011788	shares
	mvst	Shares Issuable Upon Vesting Of Non Vested Shares SharesIssuableUponVestingOfNonVestedShares	3527440	shares
CY2022Q2	mvst	Shares Issuable Upon Exercise Of Capped Non Vested Shares SharesIssuableUponExerciseOfCappedNonVestedShares	660122	shares
CY2023Q2	mvst	Shares Issuable Upon Exercise Of Capped Non Vested Shares SharesIssuableUponExerciseOfCappedNonVestedShares	13349144	shares
	mvst	Shares Issuable Upon Exercise Of Capped Non Vested Shares SharesIssuableUponExerciseOfCappedNonVestedShares	331885	shares
	mvst	Shares Issuable Upon Exercise Of Capped Non Vested Shares SharesIssuableUponExerciseOfCappedNonVestedShares	13349144	shares
CY2022Q2	mvst	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	28437000	shares
CY2023Q2	mvst	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	28437000	shares
	mvst	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	28437000	shares
	mvst	Shares Issuable Upon Exercise Of Warrants SharesIssuableUponExerciseOfWarrants	28437000	shares
CY2022Q2	mvst	Shares Issuable Upon Vesting Of Earnout Shares SharesIssuableUponVestingOfEarnoutShares	19999988	shares
CY2023Q2	mvst	Shares Issuable Upon Vesting Of Earnout Shares SharesIssuableUponVestingOfEarnoutShares	19999988	shares
	mvst	Shares Issuable Upon Vesting Of Earnout Shares SharesIssuableUponVestingOfEarnoutShares	19999988	shares
	mvst	Shares Issuable Upon Vesting Of Earnout Shares SharesIssuableUponVestingOfEarnoutShares	19999988	shares
CY2022Q2	mvst	Shares Issuable That May Be Subject To Cancellation In Dollars SharesIssuableThatMayBeSubjectToCancellationInDollars	1687500	shares
CY2023Q2	mvst	Shares Issuable That May Be Subject To Cancellation In Dollars SharesIssuableThatMayBeSubjectToCancellationInDollars	1687500	shares
	mvst	Shares Issuable That May Be Subject To Cancellation In Dollars SharesIssuableThatMayBeSubjectToCancellationInDollars	1687500	shares
	mvst	Shares Issuable That May Be Subject To Cancellation In Dollars SharesIssuableThatMayBeSubjectToCancellationInDollars	1687500	shares
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	25490000	usd

Files In Submission

Name	View Source	Status
0001760689-23-000026-index-headers.html	Edgar Link	pending
0001760689-23-000026-index.html	Edgar Link	pending
0001760689-23-000026.txt	Edgar Link	pending
0001760689-23-000026-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mvst-20230630.htm	Edgar Link	pending
mvst-20230630.xsd	Edgar Link	pending
mvst20230630-ex311.htm	Edgar Link	pending
mvst20230630-ex312.htm	Edgar Link	pending
mvst20230630-ex321.htm	Edgar Link	pending
mvst20230630-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
mvst-20230630_cal.xml	Edgar Link	unprocessable
mvst-20230630_pre.xml	Edgar Link	unprocessable
mvst-20230630_lab.xml	Edgar Link	unprocessable
mvst-20230630_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mvst-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MVST
Microvast Holdings, Inc. Stock $mvst

2023 Q3 Form 10-Q Financial Statement

#000176068923000026 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST Microvast Holdings, Inc. Stock $mvst

2023 Q3 Form 10-Q Financial Statement

#000176068923000026 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST
Microvast Holdings, Inc. Stock $mvst